Halozyme Therapeutics, Inc.Equity-NMS: HALO
Equity-NMS: HALO
$48.41
+2.77
(5:36 pm IST)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$48.41
Open
$48.41
Today’s high
$48.78
Today’s low
$47.40
52W low
$33.15
52W high
$65.5327
1Y
21.84%
5Y
20.81%
PE
15.84
EPS (TTM)
3.06
Shares O/S
127.23M
Market cap
6.16B
Insights
HALO is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. The Company’s ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, its commercially validated solution is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids, with a focus on reducing treatment burden for patients.

It also develops, manufactures, and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED, partnered commercial products and ongoing product development programs with several pharmaceutical companies. It markets and sells Hylenex recombinant, which is a formulation of rHuPH20. It markets and sells its proprietary product XYOSTED for SC administration of testosterone replacement therapy (TRT) in adult males. .


FAQs

Can I buy Halozyme Therapeutics, Inc. shares in India?
How to buy Halozyme Therapeutics, Inc. shares in India?
What is the share price of Halozyme Therapeutics, Inc.?
What is the Market Capitalization of Halozyme Therapeutics, Inc.?
What is the PE ratio of Halozyme Therapeutics, Inc.?
Is Halozyme Therapeutics, Inc. a good stock to buy?
In which sector / industry does Halozyme Therapeutics, Inc. operate?